TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer-Reference-Cited by-同舟云学术

TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer

Published:2014-12-04 Issue:1 Volume:56 Page:31-37
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Connolly Roisin M.,Leal Jeffrey P.,Goetz Matthew P.,Zhang Zhe,Zhou Xian C.,Jacobs Lisa K.,Mhlanga Joyce,O Joo H,Carpenter John,Storniolo Anna Maria,Watkins Stanley,Fetting John H.,Miller Robert S.,Sideras Kostandinos,Jeter Stacie C.,Walsh Bridget,Powers Penny,Zorzi Jane,Boughey Judy C.,Davidson Nancy E.,Carey Lisa A.,Wolff Antonio C.,Khouri Nagi,Gabrielson Edward,Wahl Richard L.,Stearns Vered

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference21 articles.

1. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells;Munster;Cancer Res.,2001

2. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA;Kim;Cancer Res.,2003

3. Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

4. Research Issues Affecting Preoperative Systemic Therapy for Operable Breast Cancer

5. Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies;Biomedicine & Pharmacotherapy;2024-05

2. Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials;EJNMMI Research;2024-03-27

3. ¹⁸F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy;Radiology: Imaging Cancer;2024-03-01

4. Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials;2024-01-16

5. Clinical and Structural Highlights for Nanoparticle Formulations of Anticancer Drugs;Handbook of Oncobiology: From Basic to Clinical Sciences;2024